August 5, 2010
Johnson & Johnson • Merck Consumer Pharmaceuticals, Co. (JJMCP) is initiating a voluntary recall of one lot of PEPCID® COMPLETE®, lot number BEF062, and one lot of ORIGINAL STRENGTH PEPCID® AC®, lot number BFF010, from the wholesaler and retailer level. This is not a consumer level recall and the risk of a serious adverse health consequence is remote. The recall is being initiated because the potential exists for a small number of bottles within these two lots to have been punctured during the packaging process. The puncture was discovered as part of the company’s quality control processes.
JJMCP is committed to providing high quality products and we have provided our wholesalers and retailers with information about this recall.
Consumers with general questions should call our Consumer Care Center at 1-800-755-4008 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time). Consumers who have health concerns should contact their healthcare provider. Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/safety/medwatch/default.htm.
JJMCP is a U.S.-based 50/50 joint venture formed to research, develop, manufacture, market and sell consumer healthcare products in the United States, including Infants’ MYLICON®, MYLANTA®, PEPCID® COMPLETE® and PEPCID® AC®.
###
CLICK HERE TO SEE FREQUENTLY ASKED QUESTIONS
CLICK HERE TO CONTACT US
|
||||||||||||
|
||||||||||||
© Johnson & Johnson • Merck Consumer Pharmaceuticals Co. 1998-2010. All rights reserved.
The site is published by Johnson & Johnson • Merck Consumer Pharmaceuticals Co., which is solely responsible for its content.
The website and its content are intended for USA audiences only.
Questions or comments? Call 1-800-755-4008 (English) or 1-888-466-8746 (Spanish) for Customer Service.
Johnson & Johnson • Merck Consumer Pharmaceuticals Co., is a U.S. based 50/50 joint venture formed to develop and market non-prescription
products derived primarily from Merck & Co., Inc. Prescription medicines, as well as products licensed and acquired from outside sources.




